NCT05558930

Brief Summary

Previous studies showed the excitatory effect of cerebellar transcranial magnetic stimulation(TMS) on motor cortex.Investigator evaluate the effects of bilateral cerebellar TMS on Coma Recovery Scale-Revised (CRS-R) scores in patients with disorders of consciousness(DOC) in a randomized, double-blinded, sham-controlled, crossover experimental design.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 29, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 1, 2022

Completed
27 days until next milestone

First Posted

Study publicly available on registry

September 28, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

September 28, 2022

Status Verified

May 1, 2022

Enrollment Period

11 months

First QC Date

September 1, 2022

Last Update Submit

September 25, 2022

Conditions

Keywords

TMScerebellariTBSDOCMCSVS

Outcome Measures

Primary Outcomes (1)

  • Change in CRS-R Total Scores

    Whether bilateral cerebellar iTBS would improve consciousness in enrolled patients. CRS-R total score is used to measure level of consciousness of disorder.The coma recovery scale-revised(CRS-R) consists of six subscales addressing auditory, visual, motor, verbal, communication, and arousal functions.The lowest item on each subscale represents reflexive activity and the highest item represents cognitively mediated behavior. Maximum scores of each subscale are summed to obtain the total score (from 0 to 23).The score for each subscale is based on the presence or absence of a specific behavioral response to a sensory stimulus (higher scores are better).

    Baseline and directly after 5 sessions of iTBS and sham stimulation(5 days)

Secondary Outcomes (3)

  • Change in CRS-R Subscale Scores

    Baseline and directly after 5 sessions of iTBS and sham stimulation(5 days)

  • Change of Influence on EEG

    Baseline and after 5 sessions of iTBS and sham stimulation(5 days)

  • Influence of time since insult on the results

    Participants will be followed for the duration of 0.5 year

Study Arms (2)

iTBS stimulation

EXPERIMENTAL

Participants receive iTBS stimulation of bilateral cerebellar one session per day for 5 consecutive days.

Device: iTBS stimulation

sham stimulation

SHAM COMPARATOR

Participants receive sham stimulation of bilateral cerebellar one session per day for 5 consecutive days.

Device: sham stimulation

Interventions

standard iTBS burst pattern:3 pulses at 50-Hz repeated at a rate of 5-Hz; 20 trains of 10 bursts given with 8-s intervals. 600 pulses on both side of cerebellar with an interval of 5 minutes.

iTBS stimulation

Participants receive a sound stimulation with the same pattern with iTBS stimulation,but without magnetic field

sham stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • VS/UWS or MCS according to diagnostic criteria
  • Age ≥18 years
  • Written informed consent obtained

You may not qualify if:

  • Patients in coma
  • Brain injury \<1week
  • Presence of metallic hardware in close contact to the discharging coil(such as cochlear implants, or an Internal Pulse Generator or medication pumps)
  • Patients with high risks according to standard questionnaire to screen transcranial magnetic stimulation(TMS) candidates

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xijing hospital, Air Force Military Medical University

Xi'an, Shaanxi, 710032, China

RECRUITING

MeSH Terms

Conditions

Consciousness DisordersPersistent Vegetative State

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersBrain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesUnconsciousness

Central Study Contacts

Wen Jiang

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: A randomized double-blinded, sham-controlled, crossover study design is used to investigate the effects of bilateral cerebellar iTBS on patients with prolonged DOC in a VS/UWS or in a MCS state. We prospectively recruit 44 patients in VS/UWS or MCS state. Each patient will receive bilateral cerebellar iTBS and sham stimulation in random order, one session per day for 5 consecutive days, separated by a 5-day washout. TMS is performed by personalized neuro-navigation to target the cerebellar dentate nucleus. The primary research outcome is whether bilateral cerebellar iTBS, as compared to sham stimulation, will improve consciousness (as measured by changes in CRS-R total scores) in VS/UWS and MCS patients. Secondary research outcome is evaluated by Electroencephalogram(EEG), CRS-R subscore, and Glasgow Outcome Scale-Extended(GOSE) score at 3 and 6 months of enrollment.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2022

First Posted

September 28, 2022

Study Start

April 29, 2022

Primary Completion

April 1, 2023

Study Completion

October 1, 2023

Last Updated

September 28, 2022

Record last verified: 2022-05

Locations